Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

337.99
Delayed Data
As of Jul 29
 -1.51 / -0.44%
Today’s Change
201.91
Today|||52-Week Range
340.34
+31.30%
Year-to-Date

Today’s Trading

Previous close339.50
Today’s open335.21
Day’s range335.06 - 340.34
Volume2,983,794
Average volume (3 months)2,160,243
Market cap$133.2B
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.48%
Earnings growth (next 5 years)+12.32%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book3.19

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-1.17-2.17%
NVONovo Nordisk+0.95+1.63%
ABBVAbbVie-0.46-0.65%
BMYBristol-Myers Squibb+0.23+0.36%
Data as of 07/29/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$4.37
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts